ALBERT DAVID
Back to Income Statement
|
ALBERT DAVID Last 5 Year Revenue History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Sales | ₹346 Cr | ₹362 Cr | ₹342 Cr | ₹314 Cr | ₹247 Cr |
What is the latest Revenue of ALBERT DAVID ?
| Year | Revenue |
|---|---|
| Mar2025 | ₹346 Cr |
| Mar2024 | ₹362 Cr |
| Mar2023 | ₹342 Cr |
| Mar2022 | ₹314 Cr |
| Mar2021 | ₹247 Cr |
How is Revenue of ALBERT DAVID Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2025 | ₹346 Cr | -4.61 | |
| Mar2024 | ₹362 Cr | 6.12 | |
| Mar2023 | ₹342 Cr | 8.95 | |
| Mar2022 | ₹314 Cr | 26.70 | |
| Mar2021 | ₹247 Cr | - | |
Compare Revenue of peers of ALBERT DAVID
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ALBERT DAVID | ₹424.7 Cr | -3% | -7.6% | -48.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹418,768.0 Cr | -0.7% | 2% | -1.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹169,385.0 Cr | -2.1% | -2.8% | 7.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹127,242.0 Cr | -0.9% | -0.6% | 12.2% | Stock Analytics | |
| CIPLA | ₹121,093.0 Cr | -1% | -1.2% | 3.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,799.0 Cr | -0.1% | 2.3% | 2.6% | Stock Analytics | |
ALBERT DAVID Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ALBERT DAVID | -3% |
-7.6% |
-48.1% |
| SENSEX | -0.4% |
-0.2% |
2.9% |
You may also like the below Video Courses